• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Aminosaccharides
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbohydrates and carbohydrate conjugates Aminosaccharides

Benzyl 2-Acetamido-3,4,6-tri-O-benzyl-2-deoxy-a-D-glucopyranoside (CAS No. 38416-56-7): An Overview of Its Structure, Synthesis, and Applications

Benzyl 2-Acetamido-3,4,6-tri-O-benzyl-2-deoxy-a-D-glucopyranoside (CAS No. 38416-56-7) is a complex organic compound that has garnered significant attention in the fields of organic chemistry and medicinal chemistry due to its unique structural features and potential applications. This compound is a benzylated derivative of a modified glucose molecule, specifically a 2-deoxyglucose with an acetamido group at the C-2 position and benzyl protecting groups at the C-3, C-4, and C-6 positions. The presence of these functional groups imparts specific chemical and biological properties that make it a valuable intermediate in the synthesis of various pharmaceuticals and bioactive compounds.

The structure of Benzyl 2-Acetamido-3,4,6-tri-O-benzyl-2-deoxy-a-D-glucopyranoside is characterized by its hexagonal ring system with a hydroxyl group at the anomeric position (C-1) and an acetamido group at the C-2 position. The benzyl protecting groups at the C-3, C-4, and C-6 positions provide stability and facilitate selective chemical reactions. The compound's molecular formula is C₂₉H₃₅NO₆, and its molecular weight is approximately 501.59 g/mol. The high degree of substitution and the presence of multiple functional groups make this compound highly versatile for further chemical modifications.

The synthesis of Benzyl 2-Acetamido-3,4,6-tri-O-benzyl-2-deoxy-a-D-glucopyranoside typically involves several steps. One common approach starts with the protection of glucose using benzyl chloride to form the tri-benzylated derivative. Subsequently, the C-2 hydroxyl group is converted to an acetamide through acetylation with acetic anhydride in the presence of a base such as pyridine. The final step involves deprotection to remove the benzyl groups selectively or in a controlled manner to yield the desired product. This synthetic route has been optimized in various research studies to improve yield and purity.

Recent advancements in synthetic methodologies have led to more efficient and environmentally friendly processes for the preparation of Benzyl 2-Acetamido-3,4,6-tri-O-benzyl-2-deoxy-a-D-glucopyranoside. For instance, catalytic methods using palladium-based catalysts have been explored to enhance the efficiency of deprotection steps. Additionally, green chemistry principles have been applied to reduce waste and improve sustainability in the synthesis process.

In terms of applications, Benzyl 2-Acetamido-3,4,6-tri-O-benzyl-2-deoxy-a-D-glucopyranoside has shown promise in various areas of medicinal chemistry. One notable application is its use as an intermediate in the synthesis of glycosidic linkages for carbohydrate-based drugs. The acetamido group at the C-2 position can be selectively modified to introduce bioactive functionalities, making it a valuable building block for drug discovery. For example, it has been used in the development of antiviral agents targeting glycoproteins on viral surfaces.

Furthermore, Benzyl 2-Acetamido-3,4,6-tri-O-benzyl-2-deoxy-a-D-glucopyranoside has been investigated for its potential as a prodrug precursor. Prodrugs are biologically inactive compounds that are converted into active drugs within the body through metabolic processes. The benzyl protecting groups can be designed to be cleaved by specific enzymes or under certain physiological conditions, releasing the active drug moiety at the target site. This approach can improve drug delivery efficiency and reduce side effects.

In addition to its pharmaceutical applications, Benzyl 2-Acetamido-3,4,6-tri-O-benzyl-2-deoxy-a-D-glucopyranoside has also found use in analytical chemistry as a reference standard for chromatographic analyses. Its well-defined structure and high purity make it suitable for calibrating analytical instruments and validating analytical methods.

The biological activity of Benzyl 2-Acetamido-3,4,6-tri-O-benzyl-2-deoxy-a-D-glucopyranoside has been studied in several research contexts. In vitro studies have shown that this compound can inhibit glycosidase enzymes involved in carbohydrate metabolism. This property makes it a potential lead compound for developing new therapeutic agents for metabolic disorders such as diabetes mellitus. Moreover, its ability to modulate glycosidase activity may have implications for cancer research, as glycosidases play a role in tumor cell proliferation and metastasis.

The structural complexity and functional versatility of Benzyl 2-Acetamido-3,4,6-tri-O-benzyl-2-deoxy-a-D-glucopyranoside have also made it an attractive target for computational studies. Molecular modeling techniques have been employed to predict its interactions with biological targets and optimize its properties for specific applications. These computational tools provide valuable insights into the molecular mechanisms underlying its biological activity and guide experimental efforts in drug design.

In conclusion, Benzyl 2-Acetamido-3,4,6-tri-O-benzyl-2-deoxy-a-D-glucopyranoside (CAS No. 38416-56-7) is a multifaceted compound with significant potential in various scientific disciplines. Its unique structural features and chemical properties make it a valuable intermediate in pharmaceutical synthesis and a promising candidate for developing new therapeutic agents. Ongoing research continues to uncover new applications and optimize synthetic methods for this important compound.

• 13343-63-0(Benzyl 2-Acetamido-4,6-O-benzylidene-2-deoxy-a-D-glucopyranoside)
• 13343-61-8(Benzyl 2-Acetamido-4,6-O-Benzylidene-2-Deoxy-b-D-Glucopyranoside)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)